FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

318585008: Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    462391015 Propranolol hydrochloride+bendrofluazide 160mg/5mg m/r capsule en Synonym (core metadata concept) Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
    714785012 Propranolol hydrochloride+bendrofluazide 160mg/5mg m/r capsule (substance) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
    1188446019 Propranolol hydrochloride+bendrofluazide 160mg/5mg m/r capsule (product) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
    2153207013 Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2160838018 Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3379441000005110 propranololhydrochlorid 160 mg/bendrofluazid 5 mg kapsel med modificeret udløsning a 5 mg da Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
    4712211000005110 propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning Is a propranolol + diuretikum false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Diuretic (substance) false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Propranolol (substance) false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning Is a Propranolol hydrochloride + bendrofluazide false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Propranolol hydrochloride false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bendrofluazide - chemical false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bendroflumethiazide (substance) false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning Has manufactured dose form A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning Is a Product containing bendroflumethiazide and propranolol (medicinal product) false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning Has manufactured dose form Oral capsule false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning Has manufactured dose form Modified-release oral capsule false Inferred relationship Some
    propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning Is a Propranolol-containing product in oral dose form false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start